High levels of neutralizing autoantibodies against IL-1α are associated with a better prognosis in chronic polyarthritis: A follow-up study

Scandinavian Journal of Immunology

Volumn 46, Issue 4, 1997, Pages 413-418

  Jouvenne, P ^a   Fossiez, F ^b   Banchereau, J ^b   Miossec, P ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HLA DR4 ANTIGEN; INTERLEUKIN 1ALPHA; NEUTRALIZING ANTIBODY;

ADULT; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS; RISK FACTOR; SJOEGREN SYNDROME;

EID: 0030791857     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1997.d01-139.x     Document Type: Article

References (19)

1. van Zeben D, Hazes JM, Zwinderman AH, Schreuder GM, D'Amaro J, Breedveld FC. Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of followup study. Arthritis Rheum 1991;34:822-30.
2. Miossec P. Cytokine abnormalities in inflammatory arthritis. In: Emery P, ed. New Developments in Investigation and Management of Early Inflammatory Arthritis. London: Ballière Tindall Ltd, 1992:373-92.
3. Arend WP, Dayer JM. Inhibition of the production and effects of Interleukin-1 and Tumor Necrosis Factor α in rheumatoid arthritis. Arthritis Rheum 1995;38:151-60.
4. Dinarello CA. The interleukin-1 family: 10 years of discovery. FASEB J 1994;8:1314-25.
5. Bendtzen K, Svenson M, Jonsson V, Hippe E. Autoantibodies to cytokines: friends or foes? Immunol Today 1990;11:167-9.
6. Svenson M, Poulsen LK, Fomsgaard A, Bendtzen K. IgG autoantibodies against interleukin 1α in sera of normal individuals. Scand J Immunol 1989;29:489-92.
7. Saurat JH, Schifferli J, Steiger G, Dayer JM, Didierjean L. Anti-interleukin-1α autoantibodies in humans: characterization, isotype distribution, and receptor-binding inhibition. Higher frequency in Schnitzler's syndrome (urticaria and macroglobulinemia). J Allergy Clin Immunol 1991;88:244-56.
8. Suzuki H, Akama T, Okane M et al. Interleukin-1-inhibitory IgG in sera from some patients with rheumatoid arthritis. Arthritis Rheum 1989;32:1528-38.
9. Suzuki H, Kamimura J, Ayabe T, Kashiwagi H. Demonstration of neutralizing autoantibodies against IL-1α in sera from patients with rheumatoid arthritis. J Immunol 1990;145:2140-6.
10. Gallay P, Mach J-P, Carrel S. Characterization and detection of naturally occuring antibodies against IL-1α and IL-1β in normal human plasma. Eur Cytokine Netw 1991;2:329-38.
11. Hansen MB, Svenson M, Bendtzen K. Human anti-interleukin 1α antibodies. Immunol Letters 1991;30:133-40.
12. Hansen MB, Andersen V, Rohde K et al. Cytokine autoantibodies in rheumatoid arthritis. Scand J Rheumatol 1995;24:197-203.
13. Jouvenne P, Fossiez F, Garonne P, Djossou O, Banchereau J, Miossec P. Increased incidence of neutralizing autoantibodies against IL-1 α in non-destructive chronic polyarthritis. J Clin Immunol 1996;16:283-90.
14. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
15. Greenspan JS Daniels TE Talal N, Sylvester RA. The histopathology of Sjögren's syndrome in labial salivary gland biopsies. Oral Surg 1974;37:217-29.
16. Tunn EJ, Bacon PA. Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic. British J Rheum 1993;32:97-103.
17. Suzuki H, Ayabe T, Kamimura J, Hashiwagi H. Anti-IL-1α autoantibodies in patients with rheumatic diseases and in healthy subjects. Clin Exp Immunol 1991;85:407-12.
18. Elliott MJ, Maini RN, Feldman M et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 1994; 344:1105-10.
19. Garonne P, Djossou O, Fossiez F et al. Generation of a human monoclonal autoantibody that acts as a high affinity IL-1α specific inhibitor. Molecular Immunol 1996;33:649-58.